ArticleNature communications2023
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma.
Thatcher Heumann et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
71 papers cite itlatest 60 shown
this paperpooled ittrialcites it